text
"['\n4. 재무제표\n재무상태표\n제 15 기 \xa0 \xa0 \xa0 \xa0 \xa02022.12.31 현재\n제 14 기 \xa0 \xa0 \xa0 \xa0 \xa02021.12.31 현재\n제 13 기 \xa0 \xa0 \xa0 \xa0 \xa02020.12.31 현재\n(단위 : 원)\n\u3000\n제 15 기\n제 14 기\n제 13 기\n자산\n\u3000\n\u3000\n\u3000\n\u3000유동자산\n275,073,699,422\n194,274,479,152\n161,290,088,721\n\u3000\u3000현금및현금성자산\n75,402,450,649\n44,353,968,831\n31,532,110,490\n\u3000\u3000단기금융상품\n146,082,553,087\n133,570,758,907\n112,035,674,037\n\u3000\u3000매출채권및기타채권\n35,440,158,962\n3,345,311,697\n3,636,511,789\n\u3000\u3000재고자산\n1,322,297,093\n1,401,520,923\n1,268,379,873\n\u3000\u3000기타유동성금융자산\n7,338,317,125\n7,605,926,157\n4,936,511,680\n\u3000\u3000기타유동자산\n9,188,863,016\n3,826,531,547\n7,397,591,652\n\u3000\u3000당기법인세자산\n299,059,490\n170,461,090\n483,309,200\n\u3000비유동자산\n496,821,622,639\n407,319,322,380\n395,478,660,942\n\u3000\u3000장기금융상품\n100,000,000\n100,000,000\n100,000,000\n\u3000\u3000장기매출채권및기타채권\n469,595,826\n551,025,686\n619,077,734\n\u3000\u3000관계기업투자\n3,133,102,462\n3,114,297,529\n3,200,919,829\n\u3000\u3000유형자산\n443,123,830\n792,021,376\n1,549,404,023\n\u3000\u3000사용권자산\n326,147,378,584\n276,939,394,660\n346,847,678,801\n\u3000\u3000무형자산\n1,799,119,750\n2,731,772,961\n4,312,355,006\n\u3000\u3000이연법인세자산\n137,264,866,939\n97,399,677,093\n13,453,437,665\n\u3000\u3000기타금융자산\n27,464,435,248\n25,691,133,075\n25,395,787,884\n\u3000자산총계\n771,895,322,061\n601,593,801,532\n556,768,749,663\n부채\n\u3000\n\u3000\n\u3000\n\u3000유동부채\n392,285,683,546\n200,741,446,828\n187,510,885,008\n\u3000\u3000매입채무및기타채무\n98,475,462,801\n51,803,343,297\n54,847,411,544\n\u3000\u3000유동성리스부채\n100,328,992,201\n92,393,588,937\n85,277,929,736\n\u3000\u3000단기차입금\n40,000,000,000\n40,000,000,000\n40,000,000,000\n\u3000\u3000기타금융부채\n193,896,900\n3,128,226\n2,870,949\n\u3000\u3000기타유동부채\n152,800,763,793\n16,269,144,282\n6,548,812,056\n\u3000\u3000유동성이연수익\n486,567,851\n272,242,086\n833,860,723\n\u3000비유동부채\n270,564,579,990\n228,103,883,928\n271,097,213,265\n\u3000\u3000리스부채\n239,858,040,110\n197,834,003,863\n245,127,740,925\n\u3000\u3000교환사채\n14,859,713,850\n14,859,713,850\n\u3000\n\u3000\u3000순확정급여부채\n12,828,315,729\n13,793,236,569\n24,141,204,247\n\u3000\u3000충당부채\n1,646,139,022\n\u3000\n\u3000\n\u3000\u3000이연수익\n474,928,676\n634,877,909\n1,380,876,562\n\u3000\u3000장기기타채무\n897,442,603\n982,051,737\n447,391,531\n\u3000부채총계\n662,850,263,536\n428,845,330,756\n458,608,098,273\n자본\n\u3000\n\u3000\n\u3000\n\u3000자본금\n52,200,000,000\n52,200,000,000\n45,000,000,000\n\u3000기타불입자본\n348,543,061,405\n361,977,821,405\n171,129,369,122\n\u3000기타자본구성요소\n(858,941,916)\n(635,095,016)\n(567,488,110)\n\u3000이익잉여금(결손금)\n(290,839,060,964)\n(240,794,255,613)\n(117,401,229,622)\n\u3000자본총계\n109,045,058,525\n172,748,470,776\n98,160,651,390\n부채및자본총계\n771,895,322,061\n601,593,801,532\n556,768,749,663\n*주) 상기 재무제표는 주주총회 승인전 재무제표로 향후 정기주주총회에서 재무제표 승인 관련 안건이 \xa0 \xa0 \xa0 부결되거나 수정이 발생한 경우 정정보고서를 통해 그 내용 및 사유를 반영할 예정입니다.\xa0\n포괄손익계산서\n제 15 기 2022.01.01 부터 2022.12.31 까지\n제 14 기 2021.01.01 부터 2021.12.31 까지\n제 13 기 2020.01.01 부터 2020.12.31 까지\n(단위 : 원)\n\u3000\n제 15 기\n제 14 기\n제 13 기\n매출\n593,428,498,296\n247,191,153,629\n271,769,077,630\n매출원가\n602,562,565,499\n392,286,830,097\n417,495,880,871\n매출총이익(손실)\n(9,134,067,203)\n(145,095,676,468)\n(145,726,803,241)\n판매비와관리비\n58,145,640,722\n40,154,747,520\n38,983,114,608\n영업손실\n(67,279,707,925)\n(185,250,423,988)\n(184,709,917,849)\n금융수익\n2,934,782,771\n1,507,591,626\n6,619,214,224\n금융비용\n15,696,731,005\n14,906,249,763\n18,146,600,964\n기타영업외수익\n20,219,558,658\n7,213,294,360\n37,052,767,468\n기타영업외비용\n30,628,566,476\n29,602,738,226\n18,321,869,758\n관계기업투자손익\n259,740,587\n(13,856,284)\n(431,250,478)\n법인세비용차감전순손실\n(90,190,923,390)\n(221,052,382,275)\n(177,937,657,357)\n법인세비용(수익)\n(40,778,253,715)\n(87,469,449,035)\n12,465,289,341\n당기순손실\n(49,412,669,675)\n(133,582,933,240)\n(190,402,946,698)\n기타포괄손익\n2,969,017,424\n11,397,300,343\n(4,533,205,877)\n\u3000후속적으로 당기손익으로 재분류되지 않는 항목\n\u3000\n\u3000\n\u3000\n\u3000\u3000확정급여제도의 재측정요소\n3,192,864,324\n11,464,907,249\n(4,084,496,951)\n\u3000\u3000기타포괄손익-공정가치측정지분상품평가손실\n\u3000\n\u3000\n(439,696,733)\n\u3000후속적으로 당기손익으로 재분류될 수 있는 항목\n\u3000\n\u3000\n\u3000\n\u3000\u3000지분법자본변동\n(223,846,900)\n(67,606,906)\n(9,012,193)\n총포괄손실\n(46,443,652,251)\n(122,185,632,897)\n(194,936,152,575)\n주당이익(손실)\n\u3000\n\u3000\n\u3000\n\u3000기본 및 희석주당손익 (단위 : 원)\n(1,033)\n(2,985)\n(6,099)\n*주) 상기 재무제표는 주주총회 승인전 재무제표로 향후 정기주주총회에서 재무제표 승인 관련 안건이 부결되거나 \xa0 \xa0 \xa0 수정이 발생한 경우 정정보고서를 통해 그 내용 및 사유를 반영할 예정입니다.\xa0\n자본변동표\n제 15 기 2022.01.01 부터 2022.12.31 까지\n제 14 기 2021.01.01 부터 2021.12.31 까지\n제 13 기 2020.01.01 부터 2020.12.31 까지\n(단위 : 원)\n\u3000\n자본\n자본금\n기타불입자본\n기타자본구성요소\n이익잉여금(결손금)\n자본 \xa0합계\n2020.01.01 (기초자본)\n30,000,000,000\n84,780,105,812\n(118,779,184)\n77,086,214,027\n191,747,540,655\n유상증자\n15,000,000,000\n89,273,702,860\n\u3000\n\u3000\n104,273,702,860\n자기주식의 취득\n\u3000\n(2,924,439,550)\n\u3000\n\u3000\n(2,924,439,550)\n교환사채 전환\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n신종자본증권의 발행\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n신종자본증권의 상환\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n신종자본증권의 배당\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n당기순손실\n\u3000\n\u3000\n\u3000\n(190,402,946,698)\n(190,402,946,698)\n확정급여제도의 재측정요소\n\u3000\n\u3000\n\u3000\n(4,084,496,951)\n(4,084,496,951)\n지분법자본변동\n\u3000\n\u3000\n(9,012,193)\n\u3000\n(9,012,193)\n기타포괄손익-공정가치측정지분상품평가손실\n\u3000\n\u3000\n(439,696,733)\n\u3000\n(439,696,733)\n2020.12.31 (기말자본)\n45,000,000,000\n171,129,369,122\n(567,488,110)\n(117,401,229,622)\n98,160,651,390\n2021.01.01 (기초자본)\n45,000,000,000\n171,129,369,122\n(567,488,110)\n(117,401,229,622)\n98,160,651,390\n유상증자\n7,200,000,000\n115,874,052,283\n\u3000\n\u3000\n123,074,052,283\n자기주식의 취득\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n교환사채 전환\n\u3000\n500,000,000\n\u3000\n\u3000\n500,000,000\n신종자본증권의 발행\n\u3000\n74,474,400,000\n\u3000\n\u3000\n74,474,400,000\n신종자본증권의 상환\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n신종자본증권의 배당\n\u3000\n\u3000\n\u3000\n(1,275,000,000)\n(1,275,000,000)\n당기순손실\n\u3000\n\u3000\n\u3000\n(133,582,933,240)\n(133,582,933,240)\n확정급여제도의 재측정요소\n\u3000\n\u3000\n\u3000\n11,464,907,249\n11,464,907,249\n지분법자본변동\n\u3000\n\u3000\n(67,606,906)\n\u3000\n(67,606,906)\n기타포괄손익-공정가치측정지분상품평가손실\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n2021.12.31 (기말자본)\n52,200,000,000\n361,977,821,405\n(635,095,016)\n(240,794,255,613)\n172,748,470,776\n2022.01.01 (기초자본)\n52,200,000,000\n361,977,821,405\n(635,095,016)\n(240,794,255,613)\n172,748,470,776\n유상증자\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n자기주식의 취득\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n교환사채 전환\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n신종자본증권의 발행\n\u3000\n61,565,240,000\n\u3000\n\u3000\n61,565,240,000\n신종자본증권의 상환\n\u3000\n(75,000,000,000)\n\u3000\n\u3000\n(75,000,000,000)\n신종자본증권의 배당\n\u3000\n\u3000\n\u3000\n(3,825,000,000)\n(3,825,000,000)\n당기순손실\n\u3000\n\u3000\n\u3000\n(49,412,669,675)\n(49,412,669,675)\n확정급여제도의 재측정요소\n\u3000\n\u3000\n\u3000\n3,192,864,324\n3,192,864,324\n지분법자본변동\n\u3000\n\u3000\n(223,846,900)\n\u3000\n(223,846,900)\n기타포괄손익-공정가치측정지분상품평가손실\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n2022.12.31 (기말자본)\n52,200,000,000\n348,543,061,405\n(858,941,916)\n(290,839,060,964)\n109,045,058,525\n*주) 상기 재무제표는 주주총회 승인전 재무제표로 향후 정기주주총회에서 재무제표 승인 관련 안건이 부결되거나 수정이 발생한 경우 정정보고서를 \xa0 \xa0 \xa0 통해 그 내용 및 사유를 반영할 예정입니다.\xa0\n현금흐름표\n제 15 기 2022.01.01 부터 2022.12.31 까지\n제 14 기 2021.01.01 부터 2021.12.31 까지\n제 13 기 2020.01.01 부터 2020.12.31 까지\n(단위 : 원)\n\u3000\n제 15 기\n제 14 기\n제 13 기\n영업활동으로 인한 현금흐름\n175,586,446,745\n(73,824,989,914)\n(171,819,561,084)\n\u3000당기순손실\n(49,412,669,675)\n(133,582,933,240)\n(190,402,946,698)\n\u3000조정\n85,689,497,455\n54,384,156,505\n130,363,810,074\n\u3000\u3000퇴직급여\n9,083,234,956\n12,075,315,827\n11,614,509,522\n\u3000\u3000유형자산 감가상각비\n479,343,046\n783,192,070\n943,581,857\n\u3000\u3000사용권자산 감가상각비\n95,277,429,554\n94,594,945,474\n112,666,184,050\n\u3000\u3000무형자산상각비\n1,813,612,224\n1,787,373,358\n1,810,399,344\n\u3000\u3000대손상각비\n330,419,105\n(4,413,890)\n(234,850,591)\n\u3000\u3000이자비용\n15,696,731,005\n14,906,249,763\n18,146,600,964\n\u3000\u3000법인세비용(수익)\n(40,778,253,715)\n(87,469,449,035)\n12,465,289,341\n\u3000\u3000외화환산손실\n13,450,031,073\n22,272,839,960\n2,851,661,971\n\u3000\u3000재고자산감모손실\n58,730,687\n1,669,957\n4,341,376\n\u3000\u3000정비충당부채전입\n748,824,299\n\u3000\n\u3000\n\u3000\u3000유형자산 폐기손실\n71,300\n\u3000\n2,000\n\u3000\u3000리스자산 처분손실\n9,189,498\n9,910,192\n3,650,179,430\n\u3000\u3000당기손익-공정가치 측정 금융상품 평가손실\n\u3000\n533,942,231\n\u3000\n\u3000\u3000잡손실\n1,334,000,000\n\u3000\n\u3000\n\u3000\u3000리스자산 변동이익\n(66,292,262)\n(7,981,983)\n(548,779,128)\n\u3000\u3000당기손익-공정가치 측정 금융상품 평가이익\n(1,905,679,793)\n(559,527,524)\n\u3000\n\u3000\u3000자산수증이익\n\u3000\n\u3000\n(25,000,000)\n\u3000\u3000이자수익\n(2,934,782,771)\n(1,507,591,626)\n(6,619,214,224)\n\u3000\u3000외화환산이익\n(6,647,370,164)\n(3,046,174,553)\n(26,792,346,316)\n\u3000\u3000관계기업투자손익\n(259,740,587)\n13,856,284\n431,250,478\n\u3000영업활동으로인한자산ㆍ부채의변동\n138,349,546,878\n4,708,076,528\n(120,878,533,238)\n\u3000\u3000매출채권\n(31,424,092,182)\n441,300,246\n23,437,345,822\n\u3000\u3000기타채권\n(450,706,169)\n(162,283,451)\n1,474,404,305\n\u3000\u3000선급금\n(11,094,503)\n(10,997,257)\n263,277,348\n\u3000\u3000선급비용\n(5,207,719,922)\n75,830,172\n702,187,482\n\u3000\u3000부가가치세대급금\n(139,202,713)\n3,511,215,247\n128,980,560\n\u3000\u3000보증금\n\u3000\n\u3000\n4,074,018,117\n\u3000\u3000미지급금\n5,481,925,547\n1,084,083,634\n(5,888,349,495)\n\u3000\u3000미지급비용\n39,301,613,213\n(1,613,518,833)\n(42,083,184,410)\n\u3000\u3000기타유동부채\n136,532,386,585\n9,720,812,020\n(101,825,311,289)\n\u3000\u3000기타금융부채\n201,315,330\n\u3000\n\u3000\n\u3000\u3000이연수익\n54,376,532\n(1,307,617,290)\n(924,581,346)\n\u3000\u3000재고자산\n20,493,143\n(134,811,007)\n358,712,751\n\u3000\u3000장기미지급비용\n(84,609,134)\n534,660,206\n174,767,438\n\u3000\u3000사외적립자산\n(3,500,000,000)\n(6,300,000,000)\n1,433,404,489\n\u3000\u3000퇴직금의 지급\n(2,425,138,849)\n(1,130,597,159)\n(2,204,205,010)\n\u3000이자의 수취\n1,088,670,487\n352,272,563\n1,259,977,667\n\u3000법인세의 환급(납부)\n(128,598,400)\n313,437,730\n7,838,131,111\n투자활동으로 인한 현금흐름\n(13,611,897,474)\n(21,520,923,318)\n122,036,853,103\n\u3000단기금융상품의 감소\n491,853,711,186\n482,770,130,726\n930,623,825,773\n\u3000장기대여금의 감소\n81,429,860\n68,052,048\n68,366,735\n\u3000보증금의 감소\n1,268,887,849\n838,420,580\n\u3000\n\u3000단기금융상품의 증가\n(502,460,315,202)\n(504,278,950,936)\n(803,713,296,565)\n\u3000장기금융상품의 증가\n\u3000\n\u3000\n(4,500,000,000)\n\u3000유형자산의 취득\n(130,516,800)\n(25,809,423)\n(158,228,100)\n\u3000무형자산의 취득\n(826,902,974)\n(206,791,313)\n(228,814,740)\n\u3000장기대여금의 증가\n\u3000\n\u3000\n(55,000,000)\n\u3000보증금의 증가\n(3,398,191,393)\n(685,975,000)\n\u3000\n재무활동으로 인한 현금흐름\n(130,865,390,148)\n107,920,190,625\n17,983,909,671\n\u3000단기차입금의 증가\n\u3000\n\u3000\n40,000,000,000\n\u3000유상증자\n\u3000\n123,074,052,283\n104,273,702,860\n\u3000교환사채의 발행\n\u3000\n15,859,713,850\n\u3000\n\u3000신종자본증권의 발행\n61,565,240,000\n74,474,400,000\n\u3000\n\u3000유동성리스부채의 상환\n(98,474,452,566)\n(88,806,725,745)\n(105,218,752,675)\n\u3000이자의 지급\n(15,131,177,582)\n(14,906,249,763)\n(18,146,600,964)\n\u3000신종자본증권의 배당금 지급\n(3,825,000,000)\n(1,275,000,000)\n\u3000\n\u3000교환사채의 상환\n\u3000\n(500,000,000)\n\u3000\n\u3000자기주식의 취득\n\u3000\n\u3000\n(2,924,439,550)\n\u3000신종자본증권의 상환\n(75,000,000,000)\n\u3000\n\u3000\n외화표시 현금및현금성자산의 환율변동효과\n(60,677,305)\n247,580,948\n400,565,294\n현금및현금성자산의 순증감\n31,048,481,818\n12,821,858,341\n(31,398,233,016)\n기초현금및현금성자산\n44,353,968,831\n31,532,110,490\n62,930,343,506\n기말현금및현금성자산\n75,402,450,649\n44,353,968,831\n31,532,110,490\n*주) 상기 재무제표는 주주총회 승인전 재무제표로 향후 정기주주총회에서 재무제표 승인 관련 안건이 부결 \xa0 \xa0 \xa0되거나 수정이 발생한 경우 정정보고서를 통해 그 내용 및 사유를 반영할 예정입니다.\n결손금 처리계산서(이익잉여금 처분계산서)(안)\n제 15 기 2022.01.01 부터 2022.12.31 까지\n제 14 기 2021.01.01 부터 2021.12.31 까지\n제 13 기 2020.01.01 부터 2020.12.31 까지\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0(단위 : 원)\n구 \xa0분\n제 15 기\n제 14 기\n제 12 기\nI. 미처분이익잉여금(미처리결손금)\n\xa0 전기이월미처분이익잉여금(미처리결손금)\n(244,874,255,613)\n(121,481,229,622)\n73,006,214,027\n\xa0 당기순손실\n(49,412,669,675)\n(133,582,933,240)\n(190,402,946,698)\n\xa0 확정급여제도의 재측정\n3,192,864,324\n11,464,907,249\n(4,084,496,951)\n\xa0 신종자본증권 배당금\n(3,825,000,000)\n(1,275,000,000)\n-\n합 \xa0계\n(294,919,060,964)\n(244,874,255,613)\n(121,481,229,622)\nII. 이익잉여금처분액(결손금처리액)\n-\n-\n-\nIII.차기이월미처리결손금\n(294,919,060,964)\n(244,874,255,613)\n(121,481,229,622)\n*주) 상기 재무제표는 주주총회 승인전 재무제표로 향후 정기주주총회에서 재무제표 승인 관련 안건이 \xa0 \xa0 \xa0 부결되거나 수정이 발생한 경우 정정보고서를 통해 그 내용 및 사유를 반영할 예정입니다.\xa0\n']"
